Icon

COLY-MYCIN M (nda050108)- (EQ 150MG BASE/VIAL)

COLISTIMETHATE SODIUM ENDO OPERATIONS
EQ 150MG BASE/VIAL
No No
Expired Expired
None None
None No
Coly-Mycin M Parenteral is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. It is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa. This antibiotic is not indicated for infections due to Proteus or Neisseria. Coly-Mycin M Parenteral has proven clinically effective in treatment of infections due to the following gram-negative organisms: Enterobacter aerogenes, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa.
6 0 5
Total Other Developers None
Drugs with Suitability No
EQ 150MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ***** ****** ******** **** *********** ********* ******** ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** **** ************ ****** *************** ******* *********** **** **. **-**, ** & **/*, ****, ****** - **, ******, *** - ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.